Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16 Alpha,17-epoxyprogesterone
2. 16 Alpha,17-epoxyprogesterone, (16beta,17alpha)-isomer
3. 16,17-epoxy-4-pregnene-3,20-dione
1. 1097-51-4
2. 16a,17a-epoxyprogesterone
3. (6ar,6bs,8as,8bs,9ar,10as,10br)-8b-acetyl-6a,8a-dimethyl-5,6,6a,6b,7,8,8a,8b,9a,10,10a,10b-dodecahydro-1h-naphtho[2',1':4,5]indeno[1,2-b]oxiren-4(2h)-one
4. 16alpha,17alpha-epoxyprogesterone
5. 16,17-epoxyprogesterone
6. 16-alpha,17-epoxypregn-4-ene-3,20-dione
7. Chembl2112759
8. Chebi:34167
9. F2dr02g069
10. Pregn-4-ene-3,20-dione, 16-alpha,17-epoxy-
11. Nsc-18315
12. Pregn-4-ene-3,20-dione, 16,17-epoxy-, (16a)-
13. Pregn-4-ene-3,20-dione, 16,17-epoxy-, (16alpha)-
14. (1r,2s,4r,6s,7s,10s,11r)-6-acetyl-7,11-dimethyl-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadec-15-en-14-one
15. 16
16. A,17
17. A-epoxyprogesterone
18. 16a,17a-epoxy-4-pregnen-3,20-dione
19. 16-17a-epoxyprogesterone
20. (16alpha)-16,17-epoxypregn-4-ene-3,20-dione
21. Einecs 214-147-5
22. Nsc 18315
23. Unii-f2dr02g069
24. 16alpha,17-epoxypregn-4-ene-3,20-dione
25. Mfcd00055948
26. Pregn-4-ene-3,20-dione, 16,17-epoxy-, (16-alpha)-
27. 16alpha,17alpha-epoxy-4-pregnen-3,20-dione
28. Schembl4539514
29. Dtxsid501318792
30. Nsc18315
31. Zinc3982458
32. Bbl030013
33. Bdbm50407978
34. Stk801869
35. Akos005622696
36. Zk-5197
37. 16 Alpha ,17 Alpha -epoxyprogesterone
38. 16.alpha.,17-epoxyprogesterone
39. Ds-12125
40. 16alpha,17alpha-epoxyprogesterone, ~98%
41. 16alpha,17-epoxy-4-pregnene-3,20-dione
42. Cs-0145392
43. Progesterone, 16.alpha.,17-epoxy-
44. 16.alpha.,17.alpha.-epoxyprogesterone
45. 16.alpha.,17.alpha.-oxidoprogesterone
46. D70987
47. 097e514
48. A927380
49. Pregn-4-ene-3, 16,17-epoxy-, (16.alpha.)-
50. W-108705
51. 16.alpha.,17-epoxypregn-4-ene-3,20-dione
52. Q27115861
53. 16.alpha.,17.alpha.-epoxy-4-pregnene-3,20-dione
54. 16.alpha.,17.alpha.-oxidopregn-4-ene-3,20-dione
55. Pregn-4-ene-3,20-dione, 16.alpha.,17-epoxy-
56. (8r,10r,13s,16r,17s)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-20-oxa-cyclopropa[16,17]cyclopenta[a]phenanthren-3-one
| Molecular Weight | 328.4 g/mol |
|---|---|
| Molecular Formula | C21H28O3 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 328.20384475 g/mol |
| Monoisotopic Mass | 328.20384475 g/mol |
| Topological Polar Surface Area | 46.7 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 679 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 1097-51-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1097-51-4, including repackagers and relabelers. The FDA regulates 1097-51-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1097-51-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1097-51-4 supplier is an individual or a company that provides 1097-51-4 active pharmaceutical ingredient (API) or 1097-51-4 finished formulations upon request. The 1097-51-4 suppliers may include 1097-51-4 API manufacturers, exporters, distributors and traders.
1097-51-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1097-51-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1097-51-4 GMP manufacturer or 1097-51-4 GMP API supplier for your needs.
A 1097-51-4 CoA (Certificate of Analysis) is a formal document that attests to 1097-51-4's compliance with 1097-51-4 specifications and serves as a tool for batch-level quality control.
1097-51-4 CoA mostly includes findings from lab analyses of a specific batch. For each 1097-51-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1097-51-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (1097-51-4 EP), 1097-51-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1097-51-4 USP).
LOOKING FOR A SUPPLIER?
